Bottom line
Is MXISX a good fund? The bottom line
MXISX is the Investor Class share class of Empower S&P Small Cap 600 Index Fund, an index small-cap mutual fund from T. Rowe Price.
Annual fees run 0.56% — about $56 a year on every $10,000 invested, cheaper than 87% of small-cap funds we track.
It returned +5.6% over one year, +6.7% a year over five years, +9.2% a year over ten (as of Dec 31, 2025, per its prospectus).
With $1.3 billion in net assets and 607 holdings, its largest position is Dreyfus Institutional Preferred Money Market Funds (3.3%) and the top 10 make up 8.7% of the portfolio.
The closest lower-cost alternative we found is VTSIX (0.03%, 75% top-holdings overlap).
What stands out
- Low cost: cheaper than 87% of small-cap peers
- Broadly diversified (607 holdings)
Updated Nov 19, 2026
What MXISX invests in
The Fund seeks investment results that track the total return of the common stocks that comprise the Standard & Poors (S&P) SmallCap 600 Index (the Benchmark Index).
Below is a summary of the principal investment strategies of the Fund. The Fund is not actively managed but is designed to track the performance of its Benchmark Index. The Fund will, under normal circumstances, invest at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in common stocks of the companies included in the Benchmark Index. The Benchmark Index is designed to measure the performance of 600 small-size companies and represents the small cap segment of the U.S. equities market. The Fund uses the replication method of indexing, meaning the Fund seeks to own the securities contained in the Benchmark Index in as close as possible a proportion of the Fund as each stocks weight in the Benchmark Index. The Fund may focus its investments in certain sectors, such as the financial sector, to the extent that the Benchmark Index is concentrated in…
From the fund's prospectus (filed Apr 30, 2026).
MXISX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MXISX | +5.6% | +6.7% | +9.2% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What MXISX costs
On a $10,000 investment, MXISX's 0.56% expense ratio costs about $56 a year. The prospectus estimates $713 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
MXISX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Dreyfus Institutional Preferred Money Market Funds | 3.30% |
| 2 | Formfactor Inc FORM | 0.68% |
| 3 | Viasat Inc VSAT | 0.65% |
| 4 | Molina Healthcare Inc MOH | 0.64% |
| 5 | Argan Inc AGX | 0.61% |
| 6 | Element Solutions Inc ESI | 0.59% |
| 7 | Brightspring Health Services Inc BTSG | 0.59% |
| 8 | Maxlinear Inc MXL | 0.59% |
| 9 | Krystal Biotech Inc KRYS | 0.53% |
| 10 | Esco Technologies Inc ESE | 0.49% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 8.7% of the fund. See all top 25 holdings and asset mix →